May 12, 2026

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Conexiant

May 12, 2026

HPV Vaccine Uptake Varied Widely Across US States

Analysis of more than 16,000 US adolescents found substantial variation in HPV vaccination uptake both across and within census regions

Conexiant

May 11, 2026

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

Conexiant

May 11, 2026

Health, Social Needs Tied to Absences

National survey data suggest overlapping chronic health and social needs are associated with higher rates of illness-related missed school days among US children.

Conexiant

May 06, 2026

31 Live Births Reported Following Uterus Transplant

Single-center series details maternal, obstetric, and neonatal outcomes among recipients with uterine-factor infertility

Conexiant

May 06, 2026

Cervical Cancer Trends Differ by Age

Recent declines among women younger than 35 years contrasted with rising long-term incidence among women aged 35 to 49 years in Puerto Rico

Conexiant

May 05, 2026

RSV Prevention Tied to Lower Infant Acute Care Use

Data suggest fewer respiratory syncytial virus–associated hospitalizations and emergency department visits among the youngest infants during the second season of routine prevention product use.

Conexiant

May 04, 2026

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

Conexiant

April 24, 2026

Nirsevimab Linked to Lower Infant Hospitalization Risk Than Maternal Vaccine

First real-world comparison shows lower hospitalization and severe illness rates with infant immunization vs maternal vaccination.

Conexiant

April 24, 2026

Varicella Pneumonia Requires IV Acyclovir

Case highlights need for early intravenous antiviral treatment in adults with rash and hypoxia

Conexiant